{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:17:30Z","timestamp":1716823050353},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.transproceed.2013.01.067","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T02:45:36Z","timestamp":1376448336000},"page":"2331-2336","source":"Crossref","is-referenced-by-count":8,"title":["Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation"],"prefix":"10.1016","volume":"45","author":[{"given":"O.","family":"Guillaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.C.","family":"Gurram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Puglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Adeyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.L.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Selzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.transproceed.2013.01.067_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MOT.0b013e32832b1f1d","article-title":"Is recurrent hepatitis C worse with living donors?","volume":"14","author":"Kuo","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2013.01.067_bib2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1600-6143.2009.02702.x","article-title":"A\u00a0practical guide to the management of HCV infection following liver transplantation","volume":"9","author":"Watt","year":"2009","journal-title":"Am J\u00a0Transplant"},{"issue":"10 suppl 1","key":"10.1016\/j.transproceed.2013.01.067_bib3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1053\/jlts.2002.35781","article-title":"Natural history of recurrent hepatitis C","volume":"8","author":"Berenguer","year":"2002","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.transproceed.2013.01.067_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jhep.2007.06.013","article-title":"Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma","volume":"47","author":"Melum","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2013.01.067_bib5","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/lt.21646","article-title":"The natural history of recurrent hepatitis C and what influences this","volume":"14","author":"Gane","year":"2008","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.transproceed.2013.01.067_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/TP.0b013e3181bd783c","article-title":"Antiviral treatment of\u00a0recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome","volume":"88","author":"Selzner","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2013.01.067_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.transproceed.2013.01.067_bib8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.transproceed.2013.01.067_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","article-title":"Liver disease and the renin-angiotensin system: recent discoveries and clinical implications","volume":"23","author":"Lubel","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2013.01.067_bib10","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1111\/j.1440-1746.2006.04663.x","article-title":"Blockade of renin-angiotensin system in antifibrotic therapy","volume":"22","author":"Yoshiji","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.transproceed.2013.01.067_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00029330-200801020-00013","article-title":"Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells","volume":"121","author":"Liu","year":"2008","journal-title":"Chin Med J (Engl)"},{"issue":"4 pt 1","key":"10.1016\/j.transproceed.2013.01.067_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","article-title":"Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats","volume":"34","author":"Yoshiji","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.transproceed.2013.01.067_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/oby.2007.114","article-title":"ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats","volume":"16","author":"Toblli","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.transproceed.2013.01.067_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3748\/wjg.v12.i2.322","article-title":"Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis","volume":"12","author":"Yokohama","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"4 pt 1","key":"10.1016\/j.transproceed.2013.01.067_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32679","article-title":"Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C","volume":"36","author":"Terui","year":"2002","journal-title":"Hepatology"},{"issue":"48","key":"10.1016\/j.transproceed.2013.01.067_bib16","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.3748\/wjg.v11.i48.7560","article-title":"Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study","volume":"11","author":"Sookoian","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.transproceed.2013.01.067_bib17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.TP.0000128913.09774.CE","article-title":"Beneficial effect of\u00a0angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation","volume":"78","author":"Rimola","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transproceed.2013.01.067_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.transproceed.2013.01.067_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/lt.21598","article-title":"The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age","volume":"14","author":"Selzner","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.transproceed.2013.01.067_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.TP.0000095896.07048.BB","article-title":"Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C","volume":"77","author":"Machicao","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2013.01.067_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.51.2.248","article-title":"Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C","volume":"51","author":"Wali","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.transproceed.2013.01.067_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/jlts.2002.32282","article-title":"Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C","volume":"8","author":"Burak","year":"2002","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.transproceed.2013.01.067_bib23","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/jlts.2003.50264","article-title":"The role of immunosuppression in recurrence of hepatitis C","volume":"9","author":"Lake","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.transproceed.2013.01.067_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2005.01.011","article-title":"What determines the natural history of recurrent hepatitis C after liver transplantation?","volume":"42","author":"Berenguer","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.transproceed.2013.01.067_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jhep.2004.01.014","article-title":"Mechanisms of HCV reinfection and allograft damage after liver transplantation","volume":"40","author":"McCaughan","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.transproceed.2013.01.067_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/gast.2001.25480","article-title":"Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis","volume":"121","author":"Jonsson","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.transproceed.2013.01.067_bib27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br J\u00a0Pharmacol"},{"issue":"4","key":"10.1016\/j.transproceed.2013.01.067_bib28","first-page":"540","article-title":"Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4)","volume":"6","author":"Wei","year":"2000","journal-title":"World J Gastroenterol"},{"issue":"2\u20133","key":"10.1016\/j.transproceed.2013.01.067_bib29","first-page":"159","article-title":"Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis","volume":"55","author":"Tuncer","year":"2003","journal-title":"Exp Toxicol Pathol"},{"issue":"31","key":"10.1016\/j.transproceed.2013.01.067_bib30","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.3748\/wjg.v11.i31.4807","article-title":"ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9","volume":"11","author":"Li","year":"2005","journal-title":"World J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.transproceed.2013.01.067_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(01)00146-5","article-title":"Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis","volume":"35","author":"Paizis","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.transproceed.2013.01.067_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0168-8278(02)00104-6","article-title":"Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats","volume":"37","author":"Yoshiji","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.transproceed.2013.01.067_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.transproceed.2013.01.067_bib34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1440-1746.2006.04700.x","article-title":"Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis","volume":"22","author":"Ibanez","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.transproceed.2013.01.067_bib35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis","volume":"45","author":"Hirose","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.transproceed.2013.01.067_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T23:06:15Z","timestamp":1563663975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134513001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0041134513001140"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.01.067","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}